FDA Approves Botox for Crow’s-Feet

By ·
FDA Approves Botox for Crow’s-Feet featured image

The world of injectables just opened up a little. Today, the FDA approved Botox, otherwise know as botulinum toxin type A, for the temporary improvement of lateral canathal lines—aka crow’s-feet. Up until now Botox has been used off-label to treat the pesky lines that extend from the outer corners of the eyes. 

This additional indication will provide people with a new FDA approved treatment option for those seeking a smoother appearance by temporarily minimizing the appearance of crow’s-feet at the sides of the eyes, said Susan Walker, M.D., director of the Division of Dermatology and Dental Products in the FDA’s Center for Drug Evaluation and Research.
Botox was first approved to treat frown lines in 2002 and has since been given approval to treat problems ranging from an overactive bladder to migraines. Treatment for both frown lines and crow’s feet can be given at the same time, with the most common side effect in the two clinical efficacy and safety studies reported as eyelid edema.
 
Want more information? Talk to your doctor. And stay tuned to NewBeauty for more updates. 
 

Find a Doctor

Find a NewBeauty "Top Beauty Doctor" Near you

Give the Gift of Luxury

NewBeauty uses cookies for various reasons, including to analyze and improve its content and advertising. Please review our Privacy Policy and Terms of Use for more about how we use this data. By continuing to use this site, you agree to these policies.